Research and Markets has announced the addition of the "In situ Hybridization Market - Global Forecast to 2021" report to their offering.

The in situ hybridization market is projected to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are some factors expected to drive the growth of the global in situ hybridization market in the coming years.

In 2016, North America is expected to account for the largest share of the global in situ hybridization market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents.

In the coming years, the in situ hybridization market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on India, China, and Japan. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies [agreements, partnerships, collaborations, product launches, acquisitions, and expansions; and other strategies (including approvals, product enhancements, and product deployments] to increase their market shares and establish a strong foothold in the global market.

Companies Mentioned:

  • ABBott Laboratories, Inc.
  • Advanced Cell Diagnostics, Inc
  • Agilent Technologies, Inc.
  • Bio Sb, Inc.
  • Biogenex Laboratories, Inc.
  • Business Overview
  • Danaher Corporation / Leica Biosystems Nussloch GmbH
  • Exiqon A/S
  • F.Hoffmann-La Roche Ltd.
  • Financial Overview
  • Merck KGaA
  • Perkin Elmer, Inc.
  • Product Offerings
  • Recent Developments
  • Thermofisher Scientific, Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Market Overview

5 In Situ Hybridization Market, By Technique

6 In Situ Hybridization Market, By Application

7 In Situ Hybridization Market, By End-User

8 In Situ Hybridization Market, By Region

9 Competitive Landscape

10 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/9s57nj/in_situ